PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 15, 2026Bioresources and Bioprocessing0 citationsOpen Access

Methanol-based biosynthesis of p-coumaric acid by engineered Pichia pastoris

MCMengyuan ChenJFJiayu FangSWShuxian Wang

Key Points

  • This research aims to explore the use of methanol for the biosynthesis of p-coumaric acid using engineered Pichia pastoris.
  • Engineered Pichia pastoris strains were created via heterologous expression of specific enzymes.
  • A balanced push-pull strategy was implemented in the shikimate pathway to enhance carbon flux utilization.
  • Production was tested in shake-flasks and bioreactors to evaluate yield and metabolic performance.
  • The highest titer achieved was 704 ± 6 mg/L of p-coumaric acid from a moderate-copy strain.
  • High-copy strains encountered metabolic burdens during high-density fermentation, reducing efficiency.
  • The study established Pichia pastoris as an effective host for methanol-based aromatic compound production.

Abstract

p-Coumaric acid (p-CA) is a key aromatic precursor for the biosynthesis of flavonoids, stilbenoids, and other high-value phenylpropanoids. While microbial production of p-CA typically relies on sugar-based substrates, methanol offers a sustainable and cost-effective alternative, though its use for aromatic biosynthesis remains unexplored. Here, we report the first de novo production of p-CA from methanol using engineered methylotrophic yeast Pichia pastoris. Through heterologous expression of a tyrosine ammonia-lyase and implementing a balanced push-pull strategy in the shikimate pathway using feedback-resistant variants of DAHP synthase (ARO4) and chorismate mutase (ARO7), carbon flux from methanol-derived C3 and C4 precursors was effectively redirected toward aromatic biosynthesis. Shake-flask studies revealed strong gene-dosage-dependent p-CA production, but strains with high-copy numbers suffered metabolic burden under high-density fermentation. Fed-batch bioreactor cultivation demonstrated that a moderate-copy strain achieved the highest titer of 704 ± 6 mg/L, outperforming high-copy variants in robustness and scalability. This study establishes P. pastoris as a promising chassis for methanol-based aromatic production and highlights the critical trade-off between pathway amplification and cellular fitness in C1 biomanufacturing.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6a06b983e7dec685947ac3d5https://doi.org/10.1186/s40643-026-01068-7
Ask AI
Helpful
Bookmark
Share
View Full Paper